Spire Healthcare Group (LON:SPI) Reaches New 1-Year High – Should You Buy?

Shares of Spire Healthcare Group plc (LON:SPI – Get Free Report) reached a new 52-week high during trading on Friday. The company traded as high as GBX 249.50 and last traded at GBX 249, with a volume of 3,670,193 shares trading hands. The stock had previously closed at GBX 247.50.

Wall Street Analysts Forecast Growth

Separately, Royal Bank Of Canada cut shares of Spire Healthcare Group to a “sector perform” rating and reduced their price objective for the company from GBX 300 to GBX 250 in a research note on Monday, September 7th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 247.50.

Check Out Our Latest Stock Report on Spire Healthcare Group

Spire Healthcare Group Price Performance

The business has a 50 day simple moving average of GBX 247.17 and a two-hundred day simple moving average of GBX 213.65. The firm has a market capitalization of £999.49 million, a P/E ratio of -499.00, a price-to-earnings-growth ratio of 1.06 and a beta of 0.88. The company has a debt-to-equity ratio of 180.14, a quick ratio of 0.73 and a current ratio of 0.58.

Spire Healthcare Group (LON:SPI – Get Free Report) last announced its earnings results on Wednesday, September 30th. The company reported GBX (0.50) earnings per share (EPS) for the quarter. Spire Healthcare Group had a negative net margin of 0.12% and a negative return on equity of 0.26%. On average, sell-side analysts expect that Spire Healthcare Group plc will post 15.66 EPS for the current fiscal year.

Spire Healthcare Group Company Profile

(Get Free Report)

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.

See Also

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.